The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Cyclin G is a transcriptional target of the p53 tumor suppressor protein.
Open accessAbstract
Through a PCR-based differential screening method, cyclin G was identified as a novel transcriptional target of the p53 tumor suppressor gene product. In both a mouse p53 temperature-sensitive leukemic cell line and mouse embryonic fibroblasts (MEF) after gamma-irradiation, cyclin G mRNA was rapidly induced. MEF from a p53-deficient mouse expressed cyclin G at a level > 10-fold lower than that from a wild-type mouse. Using a DNA binding assay, a specific p53 binding site was identified upstream from the cyclin G gene, which functioned as a p53-dependent cis-acting element in a transient transfection assay. These results suggest that cyclin G might participate in a p53-mediated pathway to prevent tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDM2 function is supported through cyclin G1, which activates MDM2 through dephosphorylation218 and CCNG1 is a p53 target itself.219”
From Census and evaluation of p53 target genes (2017) · cites this paper as [219]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction
Liang, P., & Pardee, A. B. (1992) · Science · doi:10.1126/science.1354393 · Cited by 4,964
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Self-citationKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Research works printed but not linked: 1
- Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning. A Laboratorv Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Cited by
Sorted by citations
Items 101–200 of 449
Zhao, L., Samuels, T. L., Winckler, S., Korgaonkar, C. K., Tompkins, V. S., Horne, M. C., & Quelle, D. E. (2003) · PubMed · Cited by 126
Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression
Nozaki, M., Tada, M., Kobayashi, H., Zhang, C. L., Sawamura, Y., Abe, H., Ishii, N., & Meir, E. G. V. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.2.124 · Cited by 126
Devireddy, L. R., & Jones, C. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3778-3788.1999 · Cited by 125
Horne, M. C., Donaldson, K. L., Goolsby, G. L., Tran, D., Mulheisen, M., Hell, J. W., & Wahl, A. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12650 · Cited by 123
Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction
Ahn, J., Murphy, M. E., Kratowicz, S. A., Wang, A., Levine, A. J., & George, D. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202986 · Cited by 122
Increased apoptosis induction by 121F mutant p53
Saller, E., Tom, E., Brunori, M., Otter, M., Estreicher, A., Mack, D. H., & Iggo, R. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4424 · Cited by 124
Increased Sensitivity to UV Radiation in Mice with a p53 Point Mutation at Ser389
Bruins, W., Zwart, E., Attardi, L. D., Iwakuma, T., Hoogervorst, E. M., Beems, R. B., Miranda, B., van Oostrom, C. T. M., van den Berg, J., van den Aardweg, G. J., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8884-8894.2004 · Cited by 121
New Concepts on the Role of Human Papillomavirus in Cell Cycle Regulation
Syrjänen, S., & Syrjänen, K. J. (1999) · Annals of Medicine · doi:10.3109/07853899909115976 · Cited by 122
Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter
Shivakumar, C. V., Brown, D. R., Deb, S., & Deb, S. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6785 · Cited by 120
Fortunato, E. A., & Spector, D. H. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2033-2039.1998 · Cited by 120
GAK: a cyclin G associated kinase contains a tensin/auxilin‐like domain1
Kanaoka, Y., Kimura, S. H., Okazaki, I., Ikeda, M., & Nojima, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01484-6 · Cited by 120
Conformation-dependent phosphorylation of p53
Adler, V., Pincus, M. R., Minamoto, T., Fuchs, S. Y., Bluth, M. J., Brandt‐Rauf, P. W., Friedman, F. K., Robinson, R. C., Chen, J., Wang, X. W., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1686 · Cited by 120
Ueki, T., Toyota, M., Skinner, H., Walter, K., Yeo, C. J., Issa, J. J., Hruban, R. H., & Goggins, M. (2001) · PubMed · Cited by 118
p53: A Cell Cycle Regulator Activated by DNA Damage
Selivanova, G., & Wiman, K. G. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60253-5 · Cited by 118
Yan, Y., Shay, J. W., Wright, W. E., & Mumby, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15220 · Cited by 117
PRMT5 Modulates Splicing for Genome Integrity and Preserves Proteostasis of Hematopoietic Stem Cells
Tan, D. Q., Li, Y., Yang, C., Li, J., Tan, S. H., Chin, D. W. L., Nakamura‐Ishizu, A., Yang, H. H., & Suda, T. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.001 · Cited by 123
Adenovirus and cell cycle control
Ben-Israel, H. (2002) · Frontiers in bioscience · doi:10.2741/ben · Cited by 117
Cox, L. S. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199710)183:2 · Cited by 115
Freedman, D. A., & Levine, A. J. (1999) · PubMed · Cited by 114
A role of cyclin G in the process of apoptosis
Okamoto, K., & Prives, C. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202821 · Cited by 111
Self-citationYi, F., Saha, A., Murakami, M., Kumar, P., Knight, J. S., Cai, Q., Choudhuri, T., & Robertson, E. S. (2009) · Virology · doi:10.1016/j.virol.2009.03.027 · Cited by 117
Hupp, T. R., & Lane, D. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.18165 · Cited by 108
Sun, X., Shimizu, H., & Yamamoto, K.-I. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4489 · Cited by 106
p53-Dependent Association between Cyclin G and the B′ Subunit of Protein Phosphatase 2A
Okamoto, K., Kamibayashi, C., Serrano, M., Prives, C. L., Mumby, M. C., & Beach, D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6593 · Cited by 107
Self-citationElledge, R. M., & Lee, W. (1995) · BioEssays · doi:10.1002/bies.950171105 · Cited by 106
Shenk, J. L., Fisher, C. J., Chen, S., Zhou, X., Tillman, K. C., & Shemshedini, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103652200 · Cited by 103
Ojala, J. O., Sutinen, E. M., Salminen, A., & Pirttilä, T. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.012 · Cited by 102
Skotzko, M. J., Wu, L., Anderson, W. F., Gordon, E. M., & Hall, F. L. (1995) · PubMed · Cited by 102
Mutation of Phosphoserine 389 Affects p53 Function in Vivo
Hao, M., Lowy, A. M., Kapoor, M., Deffie, A. M., Liu, G., & Lozano, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29380 · Cited by 102
On the Concentrations of Cyclins and Cyclin-Dependent Kinases in Extracts of Cultured Human Cells
Arooz, T., Yam, C. H., Siu, W. Y., Lau, A. W. S., Li, K. K. W., & Poon, R. Y. C. (2000) · Biochemistry · doi:10.1021/bi0009643 · Cited by 100
Tumor suppressor p53 regulates heparanase gene expression
Baraz, L., Haupt, Y., Elkin, M., Peretz, T., & Vlodavsky, I. (2006) · Oncogene · doi:10.1038/sj.onc.1209425 · Cited by 98
Goldman, S. C., CHEN, C.-Y., Lansing, T. J., Gilmer, T. M., & Kastan, M. (1996) · Europe PMC (PubMed Central) · Cited by 97
Intercellular adhesions as determinants of tissue assembly and malignant invasion
Steinberg, M. S., & Foty, R. A. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2 · Cited by 43
Ori, A., Zauberman, A., Doitsh, G., Paran, N., Oren, M., & Shaul, Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.544 · Cited by 97
Brinckmann, R., Kaufmann, O., Reinartz, B., & Dietel, M. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200001)190:1 · Cited by 21
Role for p300 in Stabilization of p53 in the Response to DNA Damage
Yuan, Z.-M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Shioya, H., Utsugisawa, Y., Yokoyama, K. K., Weichselbaum, R. R., Shi, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1883 · Cited by 97
Ge, R., & Hardy, M. P. (1997) · Endocrinology · doi:10.1210/endo.138.9.5387 · Cited by 95
Tumor Suppressor Activity of AP2α Mediated through a Direct Interaction with p53
McPherson, L. A., Loktev, A. V., & Weigel, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208924200 · Cited by 95
Sun, Y., Cheung, J. M., Martel‐Pelletier, J., Pelletier, J. P., Wenger, L., Altman, R. D., Howell, D. S., & Cheung, H. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11327 · Cited by 97
Regulation of Mutant p53 Temperature-sensitive DNA Binding
Friedlander, P. A., Legros, Y., Soussi, T., & Prives, C. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25468 · Cited by 94
Wadgaonkar, R., & Collins, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13760 · Cited by 97
Reimer, C., Borras, A. M., Kurdistani, S. K., Garreau, J. R., Chung, M., Aaronson, S. A., & Lee, S. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11022 · Cited by 92
Fotedar, R., Diederich, L., & Fotedar, A. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_15 · Cited by 91
Enk, C. D., Jacob–Hirsch, J., Gal, H., Verbovetski, I., Amariglio, N., Mevorach, D., Ingber, A., Givol, D., Rechavi, G., & Hochberg, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209292 · Cited by 92
Gordon, E. M., Ravicz, J. R., Liu, S., Chawla, S. P., & Hall, F. L. (2018) · Molecular and Clinical Oncology · doi:10.3892/mco.2018.1657 · Cited by 87
Yang, J. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.6.1117 · Cited by 86
A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097
Jeay, S., Gaulis, S., Ferretti, S., Bitter, H., Ito, M., Valat, T., Murakami, M., Ruetz, S., Guthy, D. A., Rynn, C., et al. (2015) · eLife · doi:10.7554/elife.06498 · Cited by 85
Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation
Ohtsuka, T., Ryu, H., Minamishima, Y. A., Ryo, A., & Lee, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206306 · Cited by 84
Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein
Kimura, S. H., & Nojima, H. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00564.x · Cited by 85
Abarzúa, P., LoSardo, J. E., Gubler, M. L., & Neri, A. (1995) · PubMed · Cited by 83
Göhler, T., Reimann, M., Cherny, D. I., Walter, K., Warnecke, G., Kim, E. L., & Deppert, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202344200 · Cited by 82
Fiucci, G., Beaucourt, S., Duflaut, D., Lespagnol, A., Stumptner-Cuvelette, P., Géant, A., Buchwalter, G., Tuynder, M., Susini, L., Lassalle, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400177101 · Cited by 81
Induction of cell growth regulatory genes by p53.
Madden, S. L., Galella, E. A., Riley, D., Bertelsen, A. H., & Beaudry, G. A. (1996) · PubMed · Cited by 80
p53 in Tumor Progression: Life, Death, and Everything
Mowat, M. R. A. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60764-2 · Cited by 78
p45 NF‐E2 regulates expression of thromboxane synthase in megakaryocytes
DeVeaux, S., Cohen‐Kaminsky, S., Shivdasani, R. A., Andrews, N. C., Filipe, A., Kuzniak, I., Orkin, S. H., Roméo, P., & Mignotte, V. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5654 · Cited by 77
Don, A. S. A., Dallapiazza, R. F., Bennin, D. A., Brake, T., Cowan, C. E., & Horne, M. C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.09.023 · Cited by 77
Farmer, G. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.21.4281 · Cited by 74
Maiyar, A. C., Huang, A. J. Y., Phu, P. T., Cha, H. H., & Firestone, G. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12414 · Cited by 74
Sjöblom, T., West, A., & Lähdetie, J. (1998) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1998)31:2 · Cited by 74
Remacha, M., Santos, C., Bermejo, B., Naranda, T., & Ballesta, J. P. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49806-2 · Cited by 73
Adenovirus E1A Proteins Inhibit Activation of Transcription by p53
Steegenga, W. T., van Laar, T., Riteco, N., Mandarino, A., Shvarts, A., van der Eb, A. J., & Jochemsen, A. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2101 · Cited by 73
Casso, D. J., & Beach, D. (1996) · Molecular and General Genetics MGG · doi:10.1007/s004380050259 · Cited by 73
Self-citationSuppression of the p300-dependent mdm2negative-feedback loop induces the p53 apoptotic functionPreprint
Thomas, A. E., & White, E. (1998) · Genes & Development · doi:10.1101/gad.12.13.1975 · Cited by 72
Reduced Hepatic Tumor Incidence in Cyclin G1–Deficient Mice
Jensen, M. R., Factor, V. M., Fantozzi, A., Helin, K., Huh, C.-G., & Thorgeirsson, S. S. (2003) · Hepatology · doi:10.1053/jhep.2003.50137 · Cited by 70
Ala‐aho, R., Grenman, R. A., Seth, P. K., & Kähäri, V. (2002) · Oncogene · doi:10.1038/sj.onc.1205198 · Cited by 70
p53-Dependent Signal Transduction Induced by Stress.
Wang, X., & Ohnishi, T. (1997) · Journal of Radiation Research · doi:10.1269/jrr.38.179 · Cited by 70
Turrell, F. K., Kerr, E. M., Gao, M., Thorpe, H., Doherty, G. J., Cridge, J., Shorthouse, D., Speed, A., Samarajiwa, S., Hall, B. A., et al. (2017) · Genes & Development · doi:10.1101/gad.298463.117 · Cited by 71
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B. L., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 72
Cyclin G2 Dysregulation in Human Oral Cancer
Kim, Y., Shintani, S., Kohno, Y., Zhang, R., & Wong, D. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1926 · Cited by 68
Genetic risk for schizophrenia and psychosis in Alzheimer disease
DeMichele‐Sweet, M. A. A., Weamer, E. A., Klei, L., Vrana, D. T., Hollingshead, D. J., Seltman, H. J., Sims, R., Foroud, T., Hernández, I., Moreno–Grau, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.81 · Cited by 69
The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis
Yonish-Rouach, E. (1996) · Cellular and Molecular Life Sciences · doi:10.1007/bf01920109 · Cited by 68
Tordjman, R., Ortéga, N., Coulombel, L., Plouët, J., Roméo, P., & Lemarchandel, V. (1999) · Blood · doi:10.1182/blood.v94.7.2301.419k24_2301_2309 · Cited by 67
Higgy, N. A., Salicioni, A. M., Russo, I. H., Zhang, P. L., & Russo, J. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199712)20:4 · Cited by 40
Genomic Analysis of Rodent Pulmonary Tissue Following Bis-(2-chloroethyl) Sulfide Exposure
Dillman, J. F., Phillips, C. S., Dorsch, L. M., Croxton, M. D., Hege, A. I., Sylvester, A. J., Moran, T. S., & Sciuto, A. M. (2004) · Chemical Research in Toxicology · doi:10.1021/tx049745z · Cited by 65
Steiner, M. S., Zhang, X., Wang, Y., & Lu, Y. W. (2000) · PubMed · Cited by 65
p53 Homologue p63 Represses Epidermal Growth Factor Receptor Expression
Nishi, H., Senoo, M., Nishi, K., Murphy, B., Rikiyama, T., Matsumura, Y., Habu, S., & Johnson, A. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101241200 · Cited by 65
The single-stranded DNA end binding site of p53 coincides with the C- terminal regulatory region
Selivanova, G. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.18.3560 · Cited by 65
Inhibition of p53 Transcriptional Activity by Bcl-2 Requires Its Membrane-anchoring Domain
Froesch, B. A., Aimé, C., Leber, B. F., Andrews, D. W., & Reed, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6469 · Cited by 64
Seo, H. R., Kim, J., Bae, S., Soh, J., & Lee, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800987200 · Cited by 62
Ray, M. R., Wafa, L. A., Cheng, H., Snoek, R., Fazli, L., Gleave, M. E., & Rennie, P. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21469 · Cited by 61
Delbridge, A. R. D., Kueh, A. J., Ke, F., Zamudio, N., El-Saafin, F., Jansz, N., Wang, G., Iminitoff, M., Beck, T. J., Haupt, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.048 · Cited by 65
CyclinG Contributes to G2/M Arrest of Cells in Response to DNA Damage
Shimizu, A., Nishida, J., Ueoka, Y., Kato, K., Hachiya, T., Kuriaki, Y., & Wake, N. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8004 · Cited by 61
Zhu, N. L., Wu, L., Liu, P. X., Gordon, E. M., Anderson, W. F., Starnes, V. A., & Hall, F. L. (1997) · Circulation · doi:10.1161/01.cir.96.2.628 · Cited by 61
Psychosis in Alzheimer’s Disease
Ballard, C. G., Kales, H. C., Lyketsos, C. G., Aarsland, D., Creese, B., Mills, R., Williams, H., & Sweet, R. A. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01074-y · Cited by 63
Structure, Expression, and Chromosomal Localization of Human GAK
Kimura, S. H., Tsuruga, H., Yabuta, N., Endo, Y., & Nojima, H. (1997) · Genomics · doi:10.1006/geno.1997.4873 · Cited by 59
Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration
Kanungo, J., Zheng, Y., Amin, N. D., & Pant, H. C. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9410-6 · Cited by 60
Zimmermann, M., Don, A. S. A., Donaldson, M. S., Dallapiazza, R. F., Cowan, C. E., & Horne, M. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.376855 · Cited by 63
Regulation of Human Cytomegalovirus Gene Expression
Fortunato, E. A., & Spector, D. H. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60366-8 · Cited by 59
Boley, S. E. (2002) · Toxicological Sciences · doi:10.1093/toxsci/66.2.209 · Cited by 58
Haines, D. S. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709051772 · Cited by 58
Keeney, J. T. R., Swomley, A. M., Harris, J. L., Fiorini, A., Mitov, M. I., Marzia Perluigi, A., Rukhsana Sultana, A., & Butterfield, D. A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9287-2 · Cited by 56
Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21
Yin, Y., Zhu, A., Jin, Y. J., Liu, Y., Zhang, X., Hopkins, K. M., & Lieberman, H. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403130101 · Cited by 56
Acute response of human skin to solar radiation: regulation and function of the p53 protein
Decraene, D., Agostinis, P., Pupe, A., Haes, P. D., & Garmyn, M. (2001) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(01)00204-4 · Cited by 56
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 57
Cell cycle control of DNA replication
Fotedar, R., & Fotedar, A. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1809-9_6 · Cited by 54
Campagne, M. V. L., & Gill, R. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00580-0 · Cited by 54
Metastasis-associated protein 1 inhibits p53-induced apoptosis
Moon, H.-E., Cheon, H., & Lee, M. (2007) · Oncology Reports · doi:10.3892/or.18.5.1311 · Cited by 53
Multiple Signaling Pathways Involving ATMPreprint
Kastan, M., Lim, D., KIM, S.-T., Xu, B., & Canman, C. E. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.521 · Cited by 53
A Critical Role for Cyclin C in Promotion of the Hematopoietic Cell Cycle by Cooperation with c-Myc
Liu, Z., Ueda, T., Miyazaki, T., Tanaka, N., Mine, S., Tanaka, Y., Taniguchi, T., Yamamura, H., & Minami, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3445 · Cited by 52
Miller, S. D., Moses, K., Jayaraman, L., & Prives, C. L. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2194 · Cited by 52
Metadata
- Authors
- Okamoto, K., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Okamoto, K.
- Venue
- The EMBO Journal
- Published
- 1994-10-01
- Volume
- 13
- Issue
- 20
- Pages
- 4816-4822
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC395420
- OpenAlex
- W1823168351
- Cited by
- 455
- References
- 40
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 7 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 7 · 2016: 3 · 2015: 11 · 2014: 6 · 2013: 10 · 2012: 11
- FWCI
- 15.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of General Medical Sciences (GM 396 20-06)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- cyclin G, p53, transcription factor target genes, tumor suppressor, p53 binding sites, cis-regulatory elements, gamma irradiation, carcinogenesis, mouse embryonic fibroblasts, leukemia cell lines
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cells, Cultured, Molecular Sequence Data, Protein Binding, Transcription Factors, Tumor Cells, Cultured, Transcriptional Activation, Tumor Suppressor Protein p53, Cyclins, Mice, Cyclin G, Cyclin G1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review